355 Results (Page 12 of 15)
Phillipines Markets Research Reports
Philippines eHealth Market Analysis
This report presents a strategic analysis of the Philippines eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Philippines eHealth Market, offering unmatched value, accuracy and expert insights.
Philippines Diabetes Devices Market Analysis
The Philippines Diabetes Devices Market is expected to witness growth from $50 Mn in 2022 to $91 Mn in 2030 with a CAGR of 7.70% for the forecasted year 2022-30. Over 5 million adults in the Philippines have been diagnosed with diabetes, making it one of the most common illnesses in the globe. There is a rising need for diabetes devices in the Philippines to manage the disease as the prevalence of diabetes keeps rising in the Philippines. The market is segmented by type and by the end user. Some key players in this market include SpectruMed, RG Meditron, S.E.A. Olympus, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Philippines Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Philippines Dermatology drugs market will reach a value of $xx Mn from $37 Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as Unilab, Mercury Drug Corporation, and Southstar Drug. The market is driven by medical tourism, awareness about dermatological health, and government regulations. The dermatology drug market in the Philippines is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Philippines Sleep Disorders Market Analysis
This report presents a strategic analysis of the Philippines Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Philippines Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
Philippines Neurology Devices Market Analysis
The Philippines Neurology Devices Market size was valued at $28 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The Philippines neurology devices market is expanding as a result of the ageing population and the increased rates of neurovascular disorders, such as stroke, among the elderly. A significant increase in the healthcare industry is the main factor driving the market. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Johnson and Johnson, Integra LifeSciences, Braun Mesungen AG, Stryker, and MicroPort.
Philippines Oncology Drugs Market Analysis
By 2030, it is anticipated that the Philippines oncology drugs market will reach a value of $xx Mn from $432.17 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Oncology Drugs Market in the Philippines is dominated by a few domestic pharmaceutical companies such as United Laboratories, Pascual Laboratories, and Sannovex Pharmaceuticals. The oncology market in the Philippines is segmented into different therapeutic areas and different treatment types. The major factors affecting the Philippines oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of the Philippines.
Philippines Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Philippines Oncology Therapeutics Market will reach a value of $790 Mn from $400 Mn in 2022, growing at a CAGR of 8.9% during 2022-2030. The Oncology Therapeutics Market in the Philippines is dominated by a few domestic pharmaceutical companies such as Pascual Laboratories, TGP Group, and United Laboratories. The Oncology Therapeutics Market in the Philippines is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Philippines Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Philippines Dental Care Market Analysis
The Philippines' dental care services market size is at around $78.94 Mn in 2022 and is projected to reach $129.66 Mn in 2030, exhibiting a CAGR of 6.4% during the forecast period 2022-2030. The Philippines is the world's selfie capital, and services for cosmetic dentistry and orthodontics are growing appeal among the younger population. Key international players for clear aligners like Invisalign, K-line, and Orthero are expanding their operations to meet patient demands. This report by Insights10 is segmented by treatment type, age group, and clinical setup, and demography and provides in-depth insights into opportunities for targeting profitable prospects.
Philippines Artificial Intelligence (AI) in Healthcare Market Analysis
The Philippines Artificial Intelligence (AI) In healthcare market is projected to grow from $0.02 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by the rise in investment in healthcare infrastructure, technical expertise, and improvement in regulatory frameworks. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Lifetrack Medical Systems & Zennya.
Philippines 3D Imaging Market Analysis
The Philippines 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by technological advancements such as an increase in the resolution and accuracy of 3D imaging devices and government initiatives & investments. The market is segmented by product, application, by end-user & by portability. Some of the major players include Siemens Healthineers, GE Healthcare & Philips Healthcare
Philippines Cardiovascular Diseases Therapeutics Market Analysis
The Philippines cardiovascular disease therapeutics market is expected to witness growth from $358 Mn in 2022 to $649 Mn in 2030 with a CAGR of 7.72% for the forecasted year 2022-2030. due to the rising prevalence of cardiovascular diseases in the Philippines. Furthermore, the increase in healthcare spending in the Philippines has resulted in the expansion of the market. The Philippines cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Prosel Pharmaceuticals, Morishita-Segg'S Pharmaceuticals, and Fresenius Kabi are the major players in the Philippines cardiovascular disease therapeutics market.
Philippines Depression Therapeutics Market Analysis
The Philippines' depression therapeutics market is expected to witness growth from $22 Mn in 2022 to $35 Mn in 2030 with a CAGR of 5.7% for the forecasted year 2022-2030. The rising investments in developing depression medications in the Philippines and the growing economy of the Philippines are responsible for the expansion of the market. The Philippines depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Maridan, MedChoice Pharma, and AstraZeneca are the major players in the Philippines' depression therapeutics market.
Philippines Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Philippines liver cancer therapeutics market will reach a value of $24.4 Mn from $6.45 Mn in 2022, growing at a CAGR of 18.1% during 2022-30. The liver cancer therapeutics market in the Philippines is dominated by a few domestic pharmaceutical companies such as United Laboratories, Pascual Laboratories, and Philippine Pharma Resources. The liver cancer therapeutics market in the Philippines is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Philippines Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Philippines Lung Cancer Therapeutics Market will reach a value of $127 Mn from $66 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in the Philippines is dominated by a few domestic pharmaceutical companies such as United Laboratories, Pfizer Philippines, and Roche Philippines. The Lung Cancer Therapeutics Market in the Philippines is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Philippines lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Philippines Anti Aging Therapeutics Market Analysis
Philippines anti-aging therapeutics market is projected to grow from $1 Mn in 2022 to $5 Mn in 2030 with a CAGR of 17.03% for the year 2022-2030. The increase in disposable incomes and more investments in the R&D projects for anti-aging drugs in Philippines are the major growth drivers of the market. The Philippines anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Distriphil, PHIX Genomics, and Rejuvenate Bio are among the top players in the market.
Philippines 3D Printing Medical Devices Market Analysis
Philippines 3D Printing Medical Device Market is expected to witness growth from $7 Mn in 2022 to $23 Mn in 2030 with a CAGR of 16.80% for the forecasted year 2022-2030. As the population ages and the prevalence of chronic illnesses among the elderly rises, the market for 3D printed medical devices in the Philippines is growing. The market is segmented by application, by technology and by end user. Some key players in this market include: ATOMED Cebu, GE Healthcare, Stryker, SpectruMed, Boston Scientific and Philips Healthcare.
Philippines ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Philippines Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to witness growth from $65 Mn in 2022 to $120 Mn in 2030 with a CAGR of 8% for the year 2022-30. The increase in ADHD awareness in the Philippines as a result of various government initiatives to spearhead information about ADHD is the major growth driver of the market. The Philippines ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Farmacia Medica, Phil Pharmawealth, and Eli Lily are some of the key players in the market.
Philippines Healthcare Claims Management Market Analysis
The Philippines healthcare claims management market is projected to grow from $58.74 Mn in 2022 to $326.22 Mn by 2030, registering a CAGR of 23.22% during the forecast period of 2022 - 2030. The main factors driving the growth would be the rise in chronic disease and the ageing population, growing health insurance penetration and adoption of digital technologies. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Stash, Generali, Optum, Cognizant and Accenture.
Philippines Oncology Clinical Trials Market Analysis
The Philippines oncology clinical trials market is projected to grow from $27.8 Mn in 2022 to $44.4 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the growing cancer burden, favorable regulatory environment, and cheaper costs. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & AstraZeneca plc.
Philippines Connected Healthcare Market Analysis
The Philippines-connected healthcare market is projected to grow from $145.99 Mn in 2022 to $1112.63 Mn by 2030, registering a CAGR of 28.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing demand for telemedicine services, rising healthcare costs, shortage of healthcare professionals and government support. The market is segmented by type, function and by application. Some of the major players include Ayala Healthcare, QualiMed, MyPocketDoctor, Microsoft, IBM and Siemens Healthineers.
Philippines Neurology Clinical Trials Market Analysis
The Philippines Neurology Clinical Trials market is projected to grow from $11.5 Mn in 2022 to $18.3 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the country's growing clinical trial industry and a large pool of potential study participants. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Pfizer & Philippine Pharma Solutions, Inc.
Philippines Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Philippines infectious disease therapeutics market will reach a value of $385.2 Mn from $263.71 Mn in 2022, growing at a CAGR of 4.9% during 2022-2030. The Infectious Disease Therapeutics in the Philippines is dominated by a few domestic pharmaceutical companies such as Glovax Biotech, United Laboratories and Pharex Health Corporation. The Infectious Disease Therapeutics market in the Philippines is segmented into different therapeutic areas and different diseases type. The major factors affecting the Philippines' infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of the Philippines.
Philippines Electronic Health Records Market Analysis
The Philippines Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. The market is segmented by product, application, and end user. The Philippines EHR market will grow due to growing awareness of the benefits of EHRs. The key market players are iClinic, Medilink, Health Data Management Inc. PhilHealth, Siemens Healthineers, Cerner, and others.
Philippines Vaccines Market Analysis
This report presents a strategic analysis of the Philippines Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Philippines Vaccines Market, offering unmatched value, accuracy and expert insights.
Philippines Advanced Therapy Medicinal Products (ATMPs) Market Analysis
This report presents a strategic analysis of the Philippines Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Philippines Advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy and expert insights.